AESKU.Systems is recipient of the prestigious 2011 Frost & Sullivan Product Differentiation Excellence Award.
AESKU.Systems is recipient of the prestigious 2011 Frost & Sullivan Product Differentiation Excellence Award. The companys` extensive research capabilities and instrumentation expertise has culminated in the successful HELMED® analyser. Frost & Sullivan Honours AESKU.SYSTEMS for developing a fast and economic diagnostic automation tool for Autoimmune Diseases Read the complete report...
MMP-3 is an outstanding serological marker that can identify patients with high risk of developing bone erosions in the near future even in an early phase of the disease.
Furthermore, due to its direct implication in the joint destruction process, MMP-3 can also be used to monitor disease activity and therapy success, thereby helping physicians to create and adapt an individualized drug therapy for each patient.
After 10 years working in the autoimmunity field with headquarters in Germany and a subsidiary in the eastern USA, AESKU opens a new office in San Francisco (Oakland, California), to increase our presence and support in America.
Today the combination of most reliable results and the best possible workflow is amongst the most important requirements in any clinical laboratories because time schedules in laboratories are getting more and more tighter all around the world.
AESKU.Diagnostics GmbH & Co. KG, as a leading diagnostic company in the autoimmunity market, has been awarded with the STEP Award 2010.
Offering the most extensive product panel, AESKU provides a comprehensive platform for autoimmune disease testing. AESKU was selected for its strategically aligned and long-term funding concept.
AESKU.Systems received a honorable mention during the award ceremony of the Innovation Prize 2010 hosted in Kaiserslautern by the minister of economic affairs of the German federal state Rhineland-Palatinate.
AESKU.Diagnostics is now offering a complete autoimmune Diabetes panel allowing simultaneous determination of IA2-GAD65 Screen, IA2, GAD65 and anti-insulin.
The AESKULISA® New generation tTG and the Deamidated gliadin peptides (DGP) are now available with the following immunoglobulins: IgG, IgA, Check (IgG/IgA mixed conjugate) and GA (IgG+IgA independent conjugates provided within the same kit).
AACC meeting 2010 was this year located in the convention center Anaheim, Californa, just one kilometer away from Disneyland. The AESKU booth was situated in the international section of the exhibition.
THE AUTOIMMUNITY EXPERTS
AESKU.DIAGNOSTICS is a research-focused company, developing, manufacturing and supplying in-vitro diagnostic kits for the early detection, diagnosis and prognosis of autoimmune diseases. The company offers the largest autoimmunity IVD panel (ELISA, IFA and lab-automation) available worldwide through AESKU subsidiaries or a network of competent partners.
AESKU.DIAGNOSTICS, based in Wendelsheim, Germany, is a research-focused supplier of innovative and reliable products and services for the early detection, diagnosis and prognosis of autoimmune diseases.
© AESKU.DIAGNOSTICS 2009 | HOME | IMPRINT | CONTACT | SITEMAP | SITESEARCH